Response letter to 'chronic cutaneous lupus erythematosus induced by 5-fluorouracil'.
Cutaneous lupus erythematosus; discoid lupus erythematosus; drug induced cutaneous lupus
Journal
Expert review of clinical pharmacology
ISSN: 1751-2441
Titre abrégé: Expert Rev Clin Pharmacol
Pays: England
ID NLM: 101278296
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
10
7
2020
medline:
30
1
2021
entrez:
10
7
2020
Statut:
ppublish
Résumé
The diagnosis of cutaneous lupus erythematosus (CLE) presents a challenge due to its heterogeneous nature. This is especially true in cases of discoid lupus erythematosus (DLE), which in the past has not had clearly defined diagnostic criteria. The recent development of classification criteria for DLE has made its diagnosis more straightforward; however, some cases previously called DLE must now be reclassified.
Identifiants
pubmed: 32643978
doi: 10.1080/17512433.2020.1794616
pmc: PMC7867402
mid: NIHMS1617731
doi:
Substances chimiques
Fluorouracil
U3P01618RT
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
919-920Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR071653
Pays : United States
Commentaires et corrections
Type : CommentOn
Références
Autoimmun Rev. 2005 Jun;4(5):253-63
pubmed: 15990071
Clin Dermatol. 1992 Oct-Dec;10(4):431-41
pubmed: 1303808
Clin Dermatol. 2006 Sep-Oct;24(5):348-62
pubmed: 16966017
Br J Dermatol. 2010 Jan;162(1):91-101
pubmed: 19785596
Cureus. 2020 Apr 25;12(4):e7828
pubmed: 32467803
Autoimmun Rev. 2013 Jan;12(3):444-54
pubmed: 23000206
J Am Acad Dermatol. 2017 Aug;77(2):261-267
pubmed: 28606712
Arch Dermatol. 1994 Oct;130(10):1262-8
pubmed: 7944507
Eur J Dermatol. 2001 Jan-Feb;11(1):54-7
pubmed: 11174141